APO Research
Talk to an analyst

APO RESEARCH · REPORT

High-Purity PLGA Polymers for Long-Acting Injectables

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global High-Purity PLGA Polymers for Long-Acting Injectables Market Analysis and Forecast 2026-2032

13 August 2026217 pages

Choose your research edition.

Industry ResearchHigh-Purity PLGA Polymers for Long-Acting Injectables Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal High-Purity PLGA Polymers for Long-Acting Injectables Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal High-Purity PLGA Polymers for Long-Acting Injectables Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal High-Purity PLGA Polymers for Long-Acting Injectables Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal High-Purity PLGA Polymers for Long-Acting Injectables Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global High-Purity PLGA Polymers for Long-Acting Injectables market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

High-Purity PLGA Polymers for Long-Acting Injectables's global sales reached XX (t) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned Evonik Industries AG as the global sales leader, a title it has maintained for several consecutive years. Notably, Evonik Industries AG's performance in primary markets is also remarkable. In the Chinese market, sales were XX (t), a change of XX% from the previous year. In Europe, sales were XX (t), showing a year-on-year of XX%. In the US, sales were XX (t), a year-on-year change of XX%.

The major global manufacturers in the High-Purity PLGA Polymers for Long-Acting Injectables market include Evonik Industries AG, Corbion N.V., Ashland Inc., SEQENS, Mitsui Chemicals, Inc., Nanjing Well Pharmaceutical Group Co., Ltd., Guangzhou DiQi Pharmaceuticals Co., Ltd., Nomisma Healthcare Pvt. Ltd. and Zhejiang Langhua Pharmaceutical Co., Ltd., etc. In 2025, the top three vendors accounted for approximately % of the revenue.

Read the full market overview

In terms of production side, this report researches the High-Purity PLGA Polymers for Long-Acting Injectables production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.

In terms of consumption side, this report focuses on the sales of High-Purity PLGA Polymers for Long-Acting Injectables by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.

This report presents an overview of global market for High-Purity PLGA Polymers for Long-Acting Injectables, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of High-Purity PLGA Polymers for Long-Acting Injectables, also provides the consumption of main regions and countries. Of the upcoming market potential for High-Purity PLGA Polymers for Long-Acting Injectables, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the High-Purity PLGA Polymers for Long-Acting Injectables sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global High-Purity PLGA Polymers for Long-Acting Injectables market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for High-Purity PLGA Polymers for Long-Acting Injectables sales, projected growth trends, production technology, application and end-user industry.

High-Purity PLGA Polymers for Long-Acting Injectables Segment by Company

Evonik Industries AG

Corbion N.V.

Ashland Inc.

SEQENS

Mitsui Chemicals, Inc.

Nanjing Well Pharmaceutical Group Co., Ltd.

Guangzhou DiQi Pharmaceuticals Co., Ltd.

Nomisma Healthcare Pvt. Ltd.

Zhejiang Langhua Pharmaceutical Co., Ltd.

Hunan Er-Kang Pharmaceutical Co., Ltd.

Shanghai Libaimei Biotechnology Co., Ltd.

Zhejiang Bangyao Biomaterials Co., Ltd.

High-Purity PLGA Polymers for Long-Acting Injectables Segment by Type

PLGA 50:50

PLGA 75:25

PLGA 85:15

Other Ratios and Customized PLGA

High-Purity PLGA Polymers for Long-Acting Injectables Segment by Application

Sustained-release Microspheres

In-situ Forming Depot Systems

Biodegradable Drug-eluting Implants

Nanoparticle Drug Delivery Systems

Other Parenteral Controlled-release Applications

High-Purity PLGA Polymers for Long-Acting Injectables Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global High-Purity PLGA Polymers for Long-Acting Injectables market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of High-Purity PLGA Polymers for Long-Acting Injectables and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of High-Purity PLGA Polymers for Long-Acting Injectables.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: High-Purity PLGA Polymers for Long-Acting Injectables production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of High-Purity PLGA Polymers for Long-Acting Injectables in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of High-Purity PLGA Polymers for Long-Acting Injectables manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, High-Purity PLGA Polymers for Long-Acting Injectables sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global High-Purity PLGA Polymers for Long-Acting Injectables Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. PLGA 50:50 Major Manufacturers Table 3. PLGA 75:25 Major Manufacturers Table 4. PLGA 85:15 Major Manufacturers Table 5. Other Ratios and Customized PLGA Major Manufacturers Table 6. Global High-Purity PLGA Polymers for Long-Acting Injectables Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Sustained-release Microspheres Major Manufacturers Table 8. In-situ Forming Depot Systems Major Manufacturers Table 9. Biodegradable Drug-eluting Implants Major Manufacturers Table 10. Nanoparticle Drug Delivery Systems Major Manufacturers Table 11. Other Parenteral Controlled-release Applications Major Manufacturers Table 12. High-Purity PLGA Polymers for Long-Acting Injectables Industry Trends Table 13. High-Purity PLGA Polymers for Long-Acting Injectables Industry Drivers Table 14. High-Purity PLGA Polymers for Long-Acting Injectables Industry Opportunities and Challenges Table 15. High-Purity PLGA Polymers for Long-Acting Injectables Industry Restraints Table 16. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Growth Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (t) Table 17. Global High-Purity PLGA Polymers for Long-Acting Injectables Production by Region (2021-2026) & (t) Table 18. Global High-Purity PLGA Polymers for Long-Acting Injectables Production by Region (2027-2032) & (t) Table 19. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share by Region (2021-2026) Table 20. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share by Region (2027-2032) Table 21. Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 22. Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Region (2021-2026) & (US$ Million) Table 23. Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Region (2027-2032) & (US$ Million) Table 24. Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue Market Share by Region (2021-2026) Table 25. Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue Market Share by Region (2027-2032) Table 26. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (t) Table 27. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales by Region (2021-2026) & (t) Table 28. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales by Region (2027-2032) & (t) Table 29. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share by Region (2021-2026) Table 30. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share by Region (2027-2032) Table 31. Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Manufacturers (US$ Million) & (2021-2026) Table 32. Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue Market Share by Manufacturers (2021-2026) Table 33. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales by Manufacturers (US$ Million) & (2021-2026) Table 34. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share by Manufacturers (2021-2026) Table 35. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales Price (USD/t) of Manufacturers (2021-2026) Table 36. Global High-Purity PLGA Polymers for Long-Acting Injectables Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 37. Global High-Purity PLGA Polymers for Long-Acting Injectables Key Manufacturers Manufacturing Sites & Headquarters Table 38. Global High-Purity PLGA Polymers for Long-Acting Injectables Manufacturers, Product Type & Application Table 39. Global High-Purity PLGA Polymers for Long-Acting Injectables Manufacturers Commercialization Time Table 40. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 41. Global High-Purity PLGA Polymers for Long-Acting Injectables by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 42. Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Type (2021-2026) & (US$ Million) Table 43. Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Type (2027-2032) & (US$ Million) Table 44. Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue Market Share by Type (2021-2026) Table 45. Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue Market Share by Type (2027-2032) Table 46. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales by Type (2021-2026) & (t) Table 47. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales by Type (2027-2032) & (t) Table 48. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share by Type (2021-2026) Table 49. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share by Type (2027-2032) Table 50. Global High-Purity PLGA Polymers for Long-Acting Injectables Price by Type (2021-2026) & (USD/t) Table 51. Global High-Purity PLGA Polymers for Long-Acting Injectables Price by Type (2027-2032) & (USD/t) Table 52. Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Application (2021-2026) & (US$ Million) Table 53. Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Application (2027-2032) & (US$ Million) Table 54. Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue Market Share by Application (2021-2026) Table 55. Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue Market Share by Application (2027-2032) Table 56. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales by Application (2021-2026) & (t) Table 57. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales by Application (2027-2032) & (t) Table 58. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share by Application (2021-2026) Table 59. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share by Application (2027-2032) Table 60. Global High-Purity PLGA Polymers for Long-Acting Injectables Price by Application (2021-2026) & (USD/t) Table 61. Global High-Purity PLGA Polymers for Long-Acting Injectables Price by Application (2027-2032) & (USD/t) Table 62. Evonik Industries AG Company Information Table 63. Evonik Industries AG Business Overview Table 64. Evonik Industries AG High-Purity PLGA Polymers for Long-Acting Injectables Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 65. Evonik Industries AG High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio Table 66. Evonik Industries AG Recent Development Table 67. Corbion N.V. Company Information Table 68. Corbion N.V. Business Overview Table 69. Corbion N.V. High-Purity PLGA Polymers for Long-Acting Injectables Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 70. Corbion N.V. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio Table 71. Corbion N.V. Recent Development Table 72. Ashland Inc. Company Information Table 73. Ashland Inc. Business Overview Table 74. Ashland Inc. High-Purity PLGA Polymers for Long-Acting Injectables Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 75. Ashland Inc. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio Table 76. Ashland Inc. Recent Development Table 77. SEQENS Company Information Table 78. SEQENS Business Overview Table 79. SEQENS High-Purity PLGA Polymers for Long-Acting Injectables Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 80. SEQENS High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio Table 81. SEQENS Recent Development Table 82. Mitsui Chemicals, Inc. Company Information Table 83. Mitsui Chemicals, Inc. Business Overview Table 84. Mitsui Chemicals, Inc. High-Purity PLGA Polymers for Long-Acting Injectables Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 85. Mitsui Chemicals, Inc. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio Table 86. Mitsui Chemicals, Inc. Recent Development Table 87. Nanjing Well Pharmaceutical Group Co., Ltd. Company Information Table 88. Nanjing Well Pharmaceutical Group Co., Ltd. Business Overview Table 89. Nanjing Well Pharmaceutical Group Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 90. Nanjing Well Pharmaceutical Group Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio Table 91. Nanjing Well Pharmaceutical Group Co., Ltd. Recent Development Table 92. Guangzhou DiQi Pharmaceuticals Co., Ltd. Company Information Table 93. Guangzhou DiQi Pharmaceuticals Co., Ltd. Business Overview Table 94. Guangzhou DiQi Pharmaceuticals Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 95. Guangzhou DiQi Pharmaceuticals Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio Table 96. Guangzhou DiQi Pharmaceuticals Co., Ltd. Recent Development Table 97. Nomisma Healthcare Pvt. Ltd. Company Information Table 98. Nomisma Healthcare Pvt. Ltd. Business Overview Table 99. Nomisma Healthcare Pvt. Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 100. Nomisma Healthcare Pvt. Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio Table 101. Nomisma Healthcare Pvt. Ltd. Recent Development Table 102. Zhejiang Langhua Pharmaceutical Co., Ltd. Company Information Table 103. Zhejiang Langhua Pharmaceutical Co., Ltd. Business Overview Table 104. Zhejiang Langhua Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 105. Zhejiang Langhua Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio Table 106. Zhejiang Langhua Pharmaceutical Co., Ltd. Recent Development Table 107. Hunan Er-Kang Pharmaceutical Co., Ltd. Company Information Table 108. Hunan Er-Kang Pharmaceutical Co., Ltd. Business Overview Table 109. Hunan Er-Kang Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 110. Hunan Er-Kang Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio Table 111. Hunan Er-Kang Pharmaceutical Co., Ltd. Recent Development Table 112. Shanghai Libaimei Biotechnology Co., Ltd. Company Information Table 113. Shanghai Libaimei Biotechnology Co., Ltd. Business Overview Table 114. Shanghai Libaimei Biotechnology Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 115. Shanghai Libaimei Biotechnology Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio Table 116. Shanghai Libaimei Biotechnology Co., Ltd. Recent Development Table 117. Zhejiang Bangyao Biomaterials Co., Ltd. Company Information Table 118. Zhejiang Bangyao Biomaterials Co., Ltd. Business Overview Table 119. Zhejiang Bangyao Biomaterials Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 120. Zhejiang Bangyao Biomaterials Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio Table 121. Zhejiang Bangyao Biomaterials Co., Ltd. Recent Development Table 122. North America High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Type (2021-2026) & (US$ Million) Table 123. North America High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Type (2027-2032) & (US$ Million) Table 124. North America High-Purity PLGA Polymers for Long-Acting Injectables Sales by Type (2021-2026) & (t) Table 125. North America High-Purity PLGA Polymers for Long-Acting Injectables Sales by Type (2027-2032) & (t) Table 126. North America High-Purity PLGA Polymers for Long-Acting Injectables Sales Price by Type (2021-2026) & (USD/t) Table 127. North America High-Purity PLGA Polymers for Long-Acting Injectables Sales Price by Type (2027-2032) & (USD/t) Table 128. North America High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Application (2021-2026) & (US$ Million) Table 129. North America High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Application (2027-2032) & (US$ Million) Table 130. North America High-Purity PLGA Polymers for Long-Acting Injectables Sales by Application (2021-2026) & (t) Table 131. North America High-Purity PLGA Polymers for Long-Acting Injectables Sales by Application (2027-2032) & (t) Table 132. North America High-Purity PLGA Polymers for Long-Acting Injectables Sales Price by Application (2021-2026) & (USD/t) Table 133. North America High-Purity PLGA Polymers for Long-Acting Injectables Sales Price by Application (2027-2032) & (USD/t) Table 134. North America High-Purity PLGA Polymers for Long-Acting Injectables Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. North America High-Purity PLGA Polymers for Long-Acting Injectables Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 136. North America High-Purity PLGA Polymers for Long-Acting Injectables Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 137. North America High-Purity PLGA Polymers for Long-Acting Injectables Sales by Country (2021 VS 2025 VS 2032) & (t) Table 138. North America High-Purity PLGA Polymers for Long-Acting Injectables Sales by Country (2021-2026) & (t) Table 139. North America High-Purity PLGA Polymers for Long-Acting Injectables Sales by Country (2027-2032) & (t) Table 140. North America High-Purity PLGA Polymers for Long-Acting Injectables Sales Price by Country (2021-2026) & (USD/t) Table 141. North America High-Purity PLGA Polymers for Long-Acting Injectables Sales Price by Country (2027-2032) & (USD/t) Table 142. United States High-Purity PLGA Polymers for Long-Acting Injectables Revenue (2021-2032) & (US$ Million) Table 143. Canada High-Purity PLGA Polymers for Long-Acting Injectables Revenue (2021-2032) & (US$ Million) Table 144. Mexico High-Purity PLGA Polymers for Long-Acting Injectables Revenue (2021-2032) & (US$ Million) Table 145. Europe High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Type (2021-2026) & (US$ Million) Table 146. Europe High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Type (2027-2032) & (US$ Million) Table 147. Europe High-Purity PLGA Polymers for Long-Acting Injectables Sales by Type (2021-2026) & (t) Table 148. Europe High-Purity PLGA Polymers for Long-Acting Injectables Sales by Type (2027-2032) & (t) Table 149. Europe High-Purity PLGA Polymers for Long-Acting Injectables Sales Price by Type (2021-2026) & (USD/t) Table 150. Europe High-Purity PLGA Polymers for Long-Acting Injectables Sales Price by Type (2027-2032) & (USD/t) Table 151. Europe High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Application (2021-2026) & (US$ Million) Table 152. Europe High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Application (2027-2032) & (US$ Million) Table 153. Europe High-Purity PLGA Polymers for Long-Acting Injectables Sales by Application (2021-2026) & (t) Table 154. Europe High-Purity PLGA Polymers for Long-Acting Injectables Sales by Application (2027-2032) & (t) Table 155. Europe High-Purity PLGA Polymers for Long-Acting Injectables Sales Price by Application (2021-2026) & (USD/t) Table 156. Europe High-Purity PLGA Polymers for Long-Acting Injectables Sales Price by Application (2027-2032) & (USD/t) Table 157. Europe High-Purity PLGA Polymers for Long-Acting Injectables Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 158. Europe High-Purity PLGA Polymers for Long-Acting Injectables Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 159. Europe High-Purity PLGA Polymers for Long-Acting Injectables Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 160. Europe High-Purity PLGA Polymers for Long-Acting Injectables Sales by Country (2021 VS 2025 VS 2032) & (t) Table 161. Europe High-Purity PLGA Polymers for Long-Acting Injectables Sales by Country (2021-2026) & (t) Table 162. Europe High-Purity PLGA Polymers for Long-Acting Injectables Sales by Country (2027-2032) & (t) Table 163. Europe High-Purity PLGA Polymers for Long-Acting Injectables Sales Price by Country (2021-2026) & (USD/t) Table 164. Europe High-Purity PLGA Polymers for Long-Acting Injectables Sales Price by Country (2027-2032) & (USD/t) Table 165. Germany High-Purity PLGA Polymers for Long-Acting Injectables Revenue (2021-2032) & (US$ Million) Table 166. France High-Purity PLGA Polymers for Long-Acting Injectables Revenue (2021-2032) & (US$ Million) Table 167. U.K. High-Purity PLGA Polymers for Long-Acting Injectables Revenue (2021-2032) & (US$ Million) Table 168. Italy High-Purity PLGA Polymers for Long-Acting Injectables Revenue (2021-2032) & (US$ Million) Table 169. Russia High-Purity PLGA Polymers for Long-Acting Injectables Revenue (2021-2032) & (US$ Million) Table 170. Spain High-Purity PLGA Polymers for Long-Acting Injectables Revenue (2021-2032) & (US$ Million) Table 171. Netherlands High-Purity PLGA Polymers for Long-Acting Injectables Revenue (2021-2032) & (US$ Million) Table 172. Switzerland High-Purity PLGA Polymers for Long-Acting Injectables Revenue (2021-2032) & (US$ Million) Table 173. Sweden High-Purity PLGA Polymers for Long-Acting Injectables Revenue (2021-2032) & (US$ Million) Table 174. Poland High-Purity PLGA Polymers for Long-Acting Injectables Revenue (2021-2032) & (US$ Million) Table 175. China High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Type (2021-2026) & (US$ Million) Table 176. China High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Type (2027-2032) & (US$ Million) Table 177. China High-Purity PLGA Polymers for Long-Acting Injectables Sales by Type (2021-2026) & (t) Table 178. China High-Purity PLGA Polymers for Long-Acting Injectables Sales by Type (2027-2032) & (t) Table 179. China High-Purity PLGA Polymers for Long-Acting Injectables Sales Price by Type (2021-2026) & (USD/t) Table 180. China High-Purity PLGA Polymers for Long-Acting Injectables Sales Price by Type (2027-2032) & (USD/t) Table 181. China High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Application (2021-2026) & (US$ Million) Table 182. China High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Application (2027-2032) & (US$ Million) Table 183. China High-Purity PLGA Polymers for Long-Acting Injectables Sales by Application (2021-2026) & (t) Table 184. China High-Purity PLGA Polymers for Long-Acting Injectables Sales by Application (2027-2032) & (t) Table 185. China High-Purity PLGA Polymers for Long-Acting Injectables Sales Price by Application (2021-2026) & (USD/t) Table 186. China High-Purity PLGA Polymers for Long-Acting Injectables Sales Price by Application (2027-2032) & (USD/t) Table 187. Asia High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Type (2021-2026) & (US$ Million) Table 188. Asia High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Type (2027-2032) & (US$ Million) Table 189. Asia High-Purity PLGA Polymers for Long-Acting Injectables Sales by Type (2021-2026) & (t) Table 190. Asia High-Purity PLGA Polymers for Long-Acting Injectables Sales by Type (2027-2032) & (t) Table 191. Asia High-Purity PLGA Polymers for Long-Acting Injectables Sales Price by Type (2021-2026) & (USD/t) Table 192. Asia High-Purity PLGA Polymers for Long-Acting Injectables Sales Price by Type (2027-2032) & (USD/t) Table 193. Asia High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Application (2021-2026) & (US$ Million) Table 194. Asia High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Application (2027-2032) & (US$ Million) Table 195. Asia High-Purity PLGA Polymers for Long-Acting Injectables Sales by Application (2021-2026) & (t) Table 196. Asia High-Purity PLGA Polymers for Long-Acting Injectables Sales by Application (2027-2032) & (t) Table 197. Asia High-Purity PLGA Polymers for Long-Acting Injectables Sales Price by Application (2021-2026) & (USD/t) Table 198. Asia High-Purity PLGA Polymers for Long-Acting Injectables Sales Price by Application (2027-2032) & (USD/t) Table 199. Asia High-Purity PLGA Polymers for Long-Acting Injectables Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 200. Asia High-Purity PLGA Polymers for Long-Acting Injectables Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 201. Asia High-Purity PLGA Polymers for Long-Acting Injectables Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 202. Asia High-Purity PLGA Polymers for Long-Acting Injectables Sales by Country (2021 VS 2025 VS 2032) & (t) Table 203. Asia High-Purity PLGA Polymers for Long-Acting Injectables Sales by Country (2021-2026) & (t) Table 204. Asia High-Purity PLGA Polymers for Long-Acting Injectables Sales by Country (2027-2032) & (t) Table 205. Asia High-Purity PLGA Polymers for Long-Acting Injectables Sales Price by Country (2021-2026) & (USD/t) Table 206. Asia High-Purity PLGA Polymers for Long-Acting Injectables Sales Price by Country (2027-2032) & (USD/t) Table 207. Japan High-Purity PLGA Polymers for Long-Acting Injectables Revenue (2021-2032) & (US$ Million) Table 208. South Korea High-Purity PLGA Polymers for Long-Acting Injectables Revenue (2021-2032) & (US$ Million) Table 209. India High-Purity PLGA Polymers for Long-Acting Injectables Revenue (2021-2032) & (US$ Million) Table 210. Australia High-Purity PLGA Polymers for Long-Acting Injectables Revenue (2021-2032) & (US$ Million) Table 211. Taiwan High-Purity PLGA Polymers for Long-Acting Injectables Revenue (2021-2032) & (US$ Million) Table 212. Southeast Asia High-Purity PLGA Polymers for Long-Acting Injectables Revenue (2021-2032) & (US$ Million) Table 213. SAMEA High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Type (2021-2026) & (US$ Million) Table 214. SAMEA High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Type (2027-2032) & (US$ Million) Table 215. SAMEA High-Purity PLGA Polymers for Long-Acting Injectables Sales by Type (2021-2026) & (t) Table 216. SAMEA High-Purity PLGA Polymers for Long-Acting Injectables Sales by Type (2027-2032) & (t) Table 217. SAMEA High-Purity PLGA Polymers for Long-Acting Injectables Sales Price by Type (2021-2026) & (USD/t) Table 218. SAMEA High-Purity PLGA Polymers for Long-Acting Injectables Sales Price by Type (2027-2032) & (USD/t) Table 219. SAMEA High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Application (2021-2026) & (US$ Million) Table 220. SAMEA High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Application (2027-2032) & (US$ Million) Table 221. SAMEA High-Purity PLGA Polymers for Long-Acting Injectables Sales by Application (2021-2026) & (t) Table 222. SAMEA High-Purity PLGA Polymers for Long-Acting Injectables Sales by Application (2027-2032) & (t) Table 223. SAMEA High-Purity PLGA Polymers for Long-Acting Injectables Sales Price by Application (2021-2026) & (USD/t) Table 224. SAMEA High-Purity PLGA Polymers for Long-Acting Injectables Sales Price by Application (2027-2032) & (USD/t) Table 225. SAMEA High-Purity PLGA Polymers for Long-Acting Injectables Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 226. SAMEA High-Purity PLGA Polymers for Long-Acting Injectables Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 227. SAMEA High-Purity PLGA Polymers for Long-Acting Injectables Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 228. SAMEA High-Purity PLGA Polymers for Long-Acting Injectables Sales by Country (2021 VS 2025 VS 2032) & (t) Table 229. SAMEA High-Purity PLGA Polymers for Long-Acting Injectables Sales by Country (2021-2026) & (t) Table 230. SAMEA High-Purity PLGA Polymers for Long-Acting Injectables Sales by Country (2027-2032) & (t) Table 231. SAMEA High-Purity PLGA Polymers for Long-Acting Injectables Sales Price by Country (2021-2026) & (USD/t) Table 232. SAMEA High-Purity PLGA Polymers for Long-Acting Injectables Sales Price by Country (2027-2032) & (USD/t) Table 233. Brazil High-Purity PLGA Polymers for Long-Acting Injectables Revenue (2021-2032) & (US$ Million) Table 234. Argentina High-Purity PLGA Polymers for Long-Acting Injectables Revenue (2021-2032) & (US$ Million) Table 235. Chile High-Purity PLGA Polymers for Long-Acting Injectables Revenue (2021-2032) & (US$ Million) Table 236. Colombia High-Purity PLGA Polymers for Long-Acting Injectables Revenue (2021-2032) & (US$ Million) Table 237. Peru High-Purity PLGA Polymers for Long-Acting Injectables Revenue (2021-2032) & (US$ Million) Table 238. Saudi Arabia High-Purity PLGA Polymers for Long-Acting Injectables Revenue (2021-2032) & (US$ Million) Table 239. Israel High-Purity PLGA Polymers for Long-Acting Injectables Revenue (2021-2032) & (US$ Million) Table 240. UAE High-Purity PLGA Polymers for Long-Acting Injectables Revenue (2021-2032) & (US$ Million) Table 241. Turkey High-Purity PLGA Polymers for Long-Acting Injectables Revenue (2021-2032) & (US$ Million) Table 242. Iran High-Purity PLGA Polymers for Long-Acting Injectables Revenue (2021-2032) & (US$ Million) Table 243. Egypt High-Purity PLGA Polymers for Long-Acting Injectables Revenue (2021-2032) & (US$ Million) Table 244. Key Raw Materials Table 245. Raw Materials Key Suppliers Table 246. High-Purity PLGA Polymers for Long-Acting Injectables Distributors List Table 247. High-Purity PLGA Polymers for Long-Acting Injectables Customers List Table 248. Research Programs/Design for This Report Table 249. Authors List of This Report Table 250. Secondary Sources Table 251. Primary Sources List of Figures Figure 1. High-Purity PLGA Polymers for Long-Acting Injectables Product Image Figure 2. Global High-Purity PLGA Polymers for Long-Acting Injectables Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global High-Purity PLGA Polymers for Long-Acting Injectables Market Size Share 2021 VS 2025 VS 2032 Figure . PLGA 50:50 Image Figure 1. PLGA 75:25 Image Figure 2. PLGA 85:15 Image Figure 3. Other Ratios and Customized PLGA Image Figure 4. Global High-Purity PLGA Polymers for Long-Acting Injectables Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 5. Global High-Purity PLGA Polymers for Long-Acting Injectables Market Size Share 2021 VS 2025 VS 2032 Figure 6. Sustained-release Microspheres Image Figure 7. In-situ Forming Depot Systems Image Figure 8. Biodegradable Drug-eluting Implants Image Figure 9. Nanoparticle Drug Delivery Systems Image Figure 10. Other Parenteral Controlled-release Applications Image Figure 11. Global High-Purity PLGA Polymers for Long-Acting Injectables Capacity, Capacity Utilization (2021-2032) & (t) Figure 12. Global High-Purity PLGA Polymers for Long-Acting Injectables Production by Region: 2021 VS 2025 VS 2032 (t) Figure 13. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share by Region: 2025 Versus 2032 Figure 14. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share by Region (2021-2032) Figure 15. North America High-Purity PLGA Polymers for Long-Acting Injectables Production Growth Rate (2021-2032) & (t) Figure 16. Europe High-Purity PLGA Polymers for Long-Acting Injectables Production Growth Rate (2021-2032) & (t) Figure 17. China High-Purity PLGA Polymers for Long-Acting Injectables Production Growth Rate (2021-2032) & (t) Figure 18. Japan High-Purity PLGA Polymers for Long-Acting Injectables Production Growth Rate (2021-2032) & (t) Figure 19. Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 20. Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue (2021-2032) & (US$ Million) Figure 21. Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue Market Share by Region: 2025 Versus 2032 Figure 23. Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue Market Share by Region (2021-2032) Figure 24. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales (2021-2032) & (t) Figure 25. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 26. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share by Region (2021-2032) Figure 27. North America High-Purity PLGA Polymers for Long-Acting Injectables Sales YoY (2021-2032) & (t) Figure 28. Europe High-Purity PLGA Polymers for Long-Acting Injectables Sales YoY (2021-2032) & (t) Figure 29. China High-Purity PLGA Polymers for Long-Acting Injectables Sales YoY (2021-2032) & (t) Figure 30. Asia (Excluding China) High-Purity PLGA Polymers for Long-Acting Injectables Sales YoY (2021-2032) & (t) Figure 31. South America, Middle East and Africa High-Purity PLGA Polymers for Long-Acting Injectables Sales YoY (2021-2032) & (t) Figure 32. Global High-Purity PLGA Polymers for Long-Acting Injectables Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 33. Global High-Purity PLGA Polymers for Long-Acting Injectables Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 34. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 35. Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue Market Share by Type (2021-2032) Figure 36. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share by Type (2021-2032) Figure 37. Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue Market Share by Application (2021-2032) Figure 38. Global High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share by Application (2021-2032) Figure 39. North America High-Purity PLGA Polymers for Long-Acting Injectables Revenue Share by Type (2021-2032) Figure 40. North America High-Purity PLGA Polymers for Long-Acting Injectables Sales Share by Type (2021-2032) Figure 41. North America High-Purity PLGA Polymers for Long-Acting Injectables Revenue Share by Application (2021-2032) Figure 42. North America High-Purity PLGA Polymers for Long-Acting Injectables Sales Share by Application (2021-2032) Figure 43. North America High-Purity PLGA Polymers for Long-Acting Injectables Revenue Share by Country (2021-2032) Figure 44. North America High-Purity PLGA Polymers for Long-

Scope & coverage.

Types
  • PLGA 50:50
  • PLGA 75:25
  • PLGA 85:15
  • Other Ratios and Customized PLGA
Applications
  • Sustained-release Microspheres
  • In-situ Forming Depot Systems
  • Biodegradable Drug-eluting Implants
  • Nanoparticle Drug Delivery Systems
  • Other Parenteral Controlled-release Applications
Companies covered
  • Evonik Industries AG
  • Corbion N.V.
  • Ashland Inc.
  • SEQENS
  • Mitsui Chemicals, Inc.
  • Nanjing Well Pharmaceutical Group Co., Ltd.
  • Guangzhou DiQi Pharmaceuticals Co., Ltd.
  • Nomisma Healthcare Pvt. Ltd.
  • Zhejiang Langhua Pharmaceutical Co., Ltd.
  • Hunan Er-Kang Pharmaceutical Co., Ltd.
  • Shanghai Libaimei Biotechnology Co., Ltd.
  • Zhejiang Bangyao Biomaterials Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 High-Purity PLGA Polymers for Long-Acting Injectables Market by Type
  3. 1.2.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 PLGA 50:50
  5. 1.2.3 PLGA 75:25
  6. 1.2.4 PLGA 85:15
  7. 1.2.5 Other Ratios and Customized PLGA
  8. 1.3 High-Purity PLGA Polymers for Long-Acting Injectables Market by Application
  9. 1.3.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Sustained-release Microspheres
  11. 1.3.3 In-situ Forming Depot Systems
  12. 1.3.4 Biodegradable Drug-eluting Implants
  13. 1.3.5 Nanoparticle Drug Delivery Systems
  14. 1.3.6 Other Parenteral Controlled-release Applications
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 High-Purity PLGA Polymers for Long-Acting Injectables Market Dynamics
  1. 2.1 High-Purity PLGA Polymers for Long-Acting Injectables Industry Trends
  2. 2.2 High-Purity PLGA Polymers for Long-Acting Injectables Industry Drivers
  3. 2.3 High-Purity PLGA Polymers for Long-Acting Injectables Industry Opportunities and Challenges
  4. 2.4 High-Purity PLGA Polymers for Long-Acting Injectables Industry Restraints
3 Global High-Purity PLGA Polymers for Long-Acting Injectables Production Overview
  1. 3.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Production Capacity (2021-2032)
  2. 3.2 Global High-Purity PLGA Polymers for Long-Acting Injectables Production by Region: 2021 VS 2025 VS 2032
  3. 3.3 Global High-Purity PLGA Polymers for Long-Acting Injectables Production by Region
  4. 3.3.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Production by Region (2021-2026)
  5. 3.3.2 Global High-Purity PLGA Polymers for Long-Acting Injectables Production by Region (2027-2032)
  6. 3.3.3 Global High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share by Region (2021-2032)
  7. 3.4 North America
  8. 3.5 Europe
  9. 3.6 China
  10. 3.7 Japan
4 Global Market Growth Prospects
  1. 4.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue Estimates and Forecasts (2021-2032)
  2. 4.2 Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Region
  3. 4.2.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Region: 2021 VS 2025 VS 2032
  4. 4.2.2 Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Region (2021-2026)
  5. 4.2.3 Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Region (2027-2032)
  6. 4.2.4 Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue Market Share by Region (2021-2032)
  7. 4.3 Global High-Purity PLGA Polymers for Long-Acting Injectables Sales Estimates and Forecasts 2021-2032
  8. 4.4 Global High-Purity PLGA Polymers for Long-Acting Injectables Sales by Region
  9. 4.4.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Sales by Region: 2021 VS 2025 VS 2032
  10. 4.4.2 Global High-Purity PLGA Polymers for Long-Acting Injectables Sales by Region (2021-2026)
  11. 4.4.3 Global High-Purity PLGA Polymers for Long-Acting Injectables Sales by Region (2027-2032)
  12. 4.4.4 Global High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share by Region (2021-2032)
  13. 4.5 North America
  14. 4.6 Europe
  15. 4.7 China
  16. 4.8 Asia (Excluding China)
  17. 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
  1. 5.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Manufacturers
  2. 5.1.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Manufacturers (2021-2026)
  3. 5.1.2 Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue Market Share by Manufacturers (2021-2026)
  4. 5.1.3 Global High-Purity PLGA Polymers for Long-Acting Injectables Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 5.2 Global High-Purity PLGA Polymers for Long-Acting Injectables Sales by Manufacturers
  6. 5.2.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Sales by Manufacturers (2021-2026)
  7. 5.2.2 Global High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share by Manufacturers (2021-2026)
  8. 5.2.3 Global High-Purity PLGA Polymers for Long-Acting Injectables Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 5.3 Global High-Purity PLGA Polymers for Long-Acting Injectables Sales Price by Manufacturers (2021-2026)
  10. 5.4 Global High-Purity PLGA Polymers for Long-Acting Injectables Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 5.5 Global High-Purity PLGA Polymers for Long-Acting Injectables Key Manufacturers Manufacturing Sites & Headquarters
  12. 5.6 Global High-Purity PLGA Polymers for Long-Acting Injectables Manufacturers, Product Type & Application
  13. 5.7 Global High-Purity PLGA Polymers for Long-Acting Injectables Manufacturers Commercialization Time
  14. 5.8 Market Competitive Analysis
  15. 5.8.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Market CR5 and HHI
  16. 5.8.2 2025 High-Purity PLGA Polymers for Long-Acting Injectables Tier 1, Tier 2, and Tier 3
6 High-Purity PLGA Polymers for Long-Acting Injectables Market by Type
  1. 6.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Type
  2. 6.1.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Type (2021-2032) & (US$ Million)
  3. 6.1.2 Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue Market Share by Type (2021-2032)
  4. 6.2 Global High-Purity PLGA Polymers for Long-Acting Injectables Sales by Type
  5. 6.2.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Sales by Type (2021-2032) & (t)
  6. 6.2.2 Global High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share by Type (2021-2032)
  7. 6.3 Global High-Purity PLGA Polymers for Long-Acting Injectables Price by Type
7 High-Purity PLGA Polymers for Long-Acting Injectables Market by Application
  1. 7.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Application
  2. 7.1.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Application (2021-2032) & (US$ Million)
  3. 7.1.2 Global High-Purity PLGA Polymers for Long-Acting Injectables Revenue Market Share by Application (2021-2032)
  4. 7.2 Global High-Purity PLGA Polymers for Long-Acting Injectables Sales by Application
  5. 7.2.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Sales by Application (2021-2032) & (t)
  6. 7.2.2 Global High-Purity PLGA Polymers for Long-Acting Injectables Sales Market Share by Application (2021-2032)
  7. 7.3 Global High-Purity PLGA Polymers for Long-Acting Injectables Price by Application
8 Company Profiles
  1. 8.1 Evonik Industries AG
  2. 8.1.1 Evonik Industries AG Company Information
  3. 8.1.2 Evonik Industries AG Business Overview
  4. 8.1.3 Evonik Industries AG High-Purity PLGA Polymers for Long-Acting Injectables Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 8.1.4 Evonik Industries AG High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio
  6. 8.1.5 Evonik Industries AG Recent Developments
  7. 8.2 Corbion N.V.
  8. 8.2.1 Corbion N.V. Company Information
  9. 8.2.2 Corbion N.V. Business Overview
  10. 8.2.3 Corbion N.V. High-Purity PLGA Polymers for Long-Acting Injectables Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 8.2.4 Corbion N.V. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio
  12. 8.2.5 Corbion N.V. Recent Developments
  13. 8.3 Ashland Inc.
  14. 8.3.1 Ashland Inc. Company Information
  15. 8.3.2 Ashland Inc. Business Overview
  16. 8.3.3 Ashland Inc. High-Purity PLGA Polymers for Long-Acting Injectables Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 8.3.4 Ashland Inc. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio
  18. 8.3.5 Ashland Inc. Recent Developments
  19. 8.4 SEQENS
  20. 8.4.1 SEQENS Company Information
  21. 8.4.2 SEQENS Business Overview
  22. 8.4.3 SEQENS High-Purity PLGA Polymers for Long-Acting Injectables Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 8.4.4 SEQENS High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio
  24. 8.4.5 SEQENS Recent Developments
  25. 8.5 Mitsui Chemicals, Inc.
  26. 8.5.1 Mitsui Chemicals, Inc. Company Information
  27. 8.5.2 Mitsui Chemicals, Inc. Business Overview
  28. 8.5.3 Mitsui Chemicals, Inc. High-Purity PLGA Polymers for Long-Acting Injectables Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 8.5.4 Mitsui Chemicals, Inc. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio
  30. 8.5.5 Mitsui Chemicals, Inc. Recent Developments
  31. 8.6 Nanjing Well Pharmaceutical Group Co., Ltd.
  32. 8.6.1 Nanjing Well Pharmaceutical Group Co., Ltd. Company Information
  33. 8.6.2 Nanjing Well Pharmaceutical Group Co., Ltd. Business Overview
  34. 8.6.3 Nanjing Well Pharmaceutical Group Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 8.6.4 Nanjing Well Pharmaceutical Group Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio
  36. 8.6.5 Nanjing Well Pharmaceutical Group Co., Ltd. Recent Developments
  37. 8.7 Guangzhou DiQi Pharmaceuticals Co., Ltd.
  38. 8.7.1 Guangzhou DiQi Pharmaceuticals Co., Ltd. Company Information
  39. 8.7.2 Guangzhou DiQi Pharmaceuticals Co., Ltd. Business Overview
  40. 8.7.3 Guangzhou DiQi Pharmaceuticals Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 8.7.4 Guangzhou DiQi Pharmaceuticals Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio
  42. 8.7.5 Guangzhou DiQi Pharmaceuticals Co., Ltd. Recent Developments
  43. 8.8 Nomisma Healthcare Pvt. Ltd.
  44. 8.8.1 Nomisma Healthcare Pvt. Ltd. Company Information
  45. 8.8.2 Nomisma Healthcare Pvt. Ltd. Business Overview
  46. 8.8.3 Nomisma Healthcare Pvt. Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 8.8.4 Nomisma Healthcare Pvt. Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio
  48. 8.8.5 Nomisma Healthcare Pvt. Ltd. Recent Developments
  49. 8.9 Zhejiang Langhua Pharmaceutical Co., Ltd.
  50. 8.9.1 Zhejiang Langhua Pharmaceutical Co., Ltd. Company Information
  51. 8.9.2 Zhejiang Langhua Pharmaceutical Co., Ltd. Business Overview
  52. 8.9.3 Zhejiang Langhua Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 8.9.4 Zhejiang Langhua Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio
  54. 8.9.5 Zhejiang Langhua Pharmaceutical Co., Ltd. Recent Developments
  55. 8.10 Hunan Er-Kang Pharmaceutical Co., Ltd.
  56. 8.10.1 Hunan Er-Kang Pharmaceutical Co., Ltd. Company Information
  57. 8.10.2 Hunan Er-Kang Pharmaceutical Co., Ltd. Business Overview
  58. 8.10.3 Hunan Er-Kang Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 8.10.4 Hunan Er-Kang Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio
  60. 8.10.5 Hunan Er-Kang Pharmaceutical Co., Ltd. Recent Developments
  61. 8.11 Shanghai Libaimei Biotechnology Co., Ltd.
  62. 8.11.1 Shanghai Libaimei Biotechnology Co., Ltd. Company Information
  63. 8.11.2 Shanghai Libaimei Biotechnology Co., Ltd. Business Overview
  64. 8.11.3 Shanghai Libaimei Biotechnology Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 8.11.4 Shanghai Libaimei Biotechnology Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio
  66. 8.11.5 Shanghai Libaimei Biotechnology Co., Ltd. Recent Developments
  67. 8.12 Zhejiang Bangyao Biomaterials Co., Ltd.
  68. 8.12.1 Zhejiang Bangyao Biomaterials Co., Ltd. Company Information
  69. 8.12.2 Zhejiang Bangyao Biomaterials Co., Ltd. Business Overview
  70. 8.12.3 Zhejiang Bangyao Biomaterials Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 8.12.4 Zhejiang Bangyao Biomaterials Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio
  72. 8.12.5 Zhejiang Bangyao Biomaterials Co., Ltd. Recent Developments
9 North America
  1. 9.1 North America High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Type
  2. 9.1.1 North America High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Type (2021-2032)
  3. 9.1.2 North America High-Purity PLGA Polymers for Long-Acting Injectables Sales by Type (2021-2032)
  4. 9.1.3 North America High-Purity PLGA Polymers for Long-Acting Injectables Price by Type (2021-2032)
  5. 9.2 North America High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Application
  6. 9.2.1 North America High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Application (2021-2032)
  7. 9.2.2 North America High-Purity PLGA Polymers for Long-Acting Injectables Sales by Application (2021-2032)
  8. 9.2.3 North America High-Purity PLGA Polymers for Long-Acting Injectables Price by Application (2021-2032)
  9. 9.3 North America High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Country
  10. 9.3.1 North America High-Purity PLGA Polymers for Long-Acting Injectables Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 North America High-Purity PLGA Polymers for Long-Acting Injectables Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 North America High-Purity PLGA Polymers for Long-Acting Injectables Price by Country (2021-2032)
  13. 9.3.4 United States
  14. 9.3.5 Canada
  15. 9.3.6 Mexico
10 Europe
  1. 10.1 Europe High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Type
  2. 10.1.1 Europe High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Type (2021-2032)
  3. 10.1.2 Europe High-Purity PLGA Polymers for Long-Acting Injectables Sales by Type (2021-2032)
  4. 10.1.3 Europe High-Purity PLGA Polymers for Long-Acting Injectables Price by Type (2021-2032)
  5. 10.2 Europe High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Application
  6. 10.2.1 Europe High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Application (2021-2032)
  7. 10.2.2 Europe High-Purity PLGA Polymers for Long-Acting Injectables Sales by Application (2021-2032)
  8. 10.2.3 Europe High-Purity PLGA Polymers for Long-Acting Injectables Price by Application (2021-2032)
  9. 10.3 Europe High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Country
  10. 10.3.1 Europe High-Purity PLGA Polymers for Long-Acting Injectables Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 10.3.2 Europe High-Purity PLGA Polymers for Long-Acting Injectables Sales by Country (2021 VS 2025 VS 2032)
  12. 10.3.3 Europe High-Purity PLGA Polymers for Long-Acting Injectables Price by Country (2021-2032)
  13. 10.3.4 Germany
  14. 10.3.5 France
  15. 10.3.6 U.K.
  16. 10.3.7 Italy
  17. 10.3.8 Russia
  18. 10.3.9 Spain
  19. 10.3.10 Netherlands
  20. 10.3.11 Switzerland
  21. 10.3.12 Sweden
11 China
  1. 11.1 China High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Type
  2. 11.1.1 China High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Type (2021-2032)
  3. 11.1.2 China High-Purity PLGA Polymers for Long-Acting Injectables Sales by Type (2021-2032)
  4. 11.1.3 China High-Purity PLGA Polymers for Long-Acting Injectables Price by Type (2021-2032)
  5. 11.2 China High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Application
  6. 11.2.1 China High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Application (2021-2032)
  7. 11.2.2 China High-Purity PLGA Polymers for Long-Acting Injectables Sales by Application (2021-2032)
  8. 11.2.3 China High-Purity PLGA Polymers for Long-Acting Injectables Price by Application (2021-2032)
12 Asia (Excluding China)
  1. 12.1 Asia High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Type
  2. 12.1.1 Asia High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Type (2021-2032)
  3. 12.1.2 Asia High-Purity PLGA Polymers for Long-Acting Injectables Sales by Type (2021-2032)
  4. 12.1.3 Asia High-Purity PLGA Polymers for Long-Acting Injectables Price by Type (2021-2032)
  5. 12.2 Asia High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Application
  6. 12.2.1 Asia High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Application (2021-2032)
  7. 12.2.2 Asia High-Purity PLGA Polymers for Long-Acting Injectables Sales by Application (2021-2032)
  8. 12.2.3 Asia High-Purity PLGA Polymers for Long-Acting Injectables Price by Application (2021-2032)
  9. 12.3 Asia High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Country
  10. 12.3.1 Asia High-Purity PLGA Polymers for Long-Acting Injectables Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 Asia High-Purity PLGA Polymers for Long-Acting Injectables Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 Asia High-Purity PLGA Polymers for Long-Acting Injectables Price by Country (2021-2032)
  13. 12.3.4 Japan
  14. 12.3.5 South Korea
  15. 12.3.6 India
  16. 12.3.7 Australia
  17. 12.3.8 Taiwan
  18. 12.3.9 Southeast Asia
13 South America, Middle East and Africa
  1. 13.1 SAMEA High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Type
  2. 13.1.1 SAMEA High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Type (2021-2032)
  3. 13.1.2 SAMEA High-Purity PLGA Polymers for Long-Acting Injectables Sales by Type (2021-2032)
  4. 13.1.3 SAMEA High-Purity PLGA Polymers for Long-Acting Injectables Price by Type (2021-2032)
  5. 13.2 SAMEA High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Application
  6. 13.2.1 SAMEA High-Purity PLGA Polymers for Long-Acting Injectables Revenue by Application (2021-2032)
  7. 13.2.2 SAMEA High-Purity PLGA Polymers for Long-Acting Injectables Sales by Application (2021-2032)
  8. 13.2.3 SAMEA High-Purity PLGA Polymers for Long-Acting Injectables Price by Application (2021-2032)
  9. 13.3 SAMEA High-Purity PLGA Polymers for Long-Acting Injectables Market Size by Country
  10. 13.3.1 SAMEA High-Purity PLGA Polymers for Long-Acting Injectables Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 13.3.2 SAMEA High-Purity PLGA Polymers for Long-Acting Injectables Sales by Country (2021 VS 2025 VS 2032)
  12. 13.3.3 SAMEA High-Purity PLGA Polymers for Long-Acting Injectables Price by Country (2021-2032)
  13. 13.3.4 Brazil
  14. 13.3.5 Argentina
  15. 13.3.6 Chile
  16. 13.3.7 Colombia
  17. 13.3.8 Peru
  18. 13.3.9 Saudi Arabia
  19. 13.3.10 Israel
  20. 13.3.11 UAE
  21. 13.3.12 Turkey
  22. 13.3.13 Iran
  23. 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
  1. 14.1 High-Purity PLGA Polymers for Long-Acting Injectables Value Chain Analysis
  2. 14.1.1 High-Purity PLGA Polymers for Long-Acting Injectables Key Raw Materials
  3. 14.1.2 Raw Materials Key Suppliers
  4. 14.1.3 Manufacturing Cost Structure
  5. 14.1.4 High-Purity PLGA Polymers for Long-Acting Injectables Production Mode & Process
  6. 14.2 High-Purity PLGA Polymers for Long-Acting Injectables Sales Channels Analysis
  7. 14.2.1 Direct Comparison with Distribution Share
  8. 14.2.2 High-Purity PLGA Polymers for Long-Acting Injectables Distributors
  9. 14.2.3 High-Purity PLGA Polymers for Long-Acting Injectables Customers
15 Concluding Insights
    16 Appendix
    1. 16.1 Reasons for Doing This Study
    2. 16.2 Research Methodology
    3. 16.3 Research Process
    4. 16.4 Authors List of This Report
    5. 16.5 Data Source
    6. 16.5.1 Secondary Sources
    7. 16.5.2 Primary Sources
    8. 16.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst